2alv | pdb_00002alv
X-ray structural analysis of SARS coronavirus 3CL proteinase in complex with designed anti-viral inhibitors
|
Overview
Design, synthesis, and biological evaluation of peptidomimetic severe, acute respiratory syndrome chymotrypsin-like protease (SARS-3CLpro), inhibitors for severe acute respiratory syndrome coronavirus (SARS-CoV), are described. These inhibitors exhibited antiviral activity against, SARS-CoV in infected cells in the micromolar range. An X-ray crystal, structure of our lead inhibitor (4) bound to SARS-3CLpro provided, important drug-design templates for the design of small-molecule, inhibitors.
About this Structure
2ALV is a Single protein structure of sequence from Human sars coronavirus with CY6 as ligand. Full crystallographic information is available from OCA.
Reference
Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors., Ghosh AK, Xi K, Ratia K, Santarsiero BD, Fu W, Harcourt BH, Rota PA, Baker SC, Johnson ME, Mesecar AD, J Med Chem. 2005 Nov 3;48(22):6767-71. PMID:16250632
Page seeded by OCA on Tue Jan 29 18:04:35 2008
